4 Ways Of Blockchain Healthcare

December 22, 2019

Blockchain technology is coming, and it may solve many of the challenges providers experience in healthcare today. But where exactly will it be effective and what use cases should organizations be looking to as they move ahead? Here, there’s much debate.

Spotlight

Glytec

Founded in 2006, Glytec is the pioneer and leader in diabetes therapy management software, enabling healthcare organizations to standardize acute and chronic care, and achieve best practice for glucose control. The company’s comprehensive eGlycemic Management System® (eGMS®) has been proven to dramatically reduce the drivers of cost and clinical variation, including hypoglycemia, readmissions, length of stay, complications and A1C levels. Its efficacy and safety have been validated by more than 60 research studies. eGMS® centers on an FDA-cleared insulin dosing solution that supports personalized intravenous and subcutaneous therapy for adult and pediatric populations.

OTHER VIDEOS

ADI Silent Switcher® Technology

video | September 21, 2022

Silent Switcher regulators and smart power stages provide new levels of performance for synchronous DC-to-DC converters....

Watch Now

Patient journey mapping is crucial to deliver the best healthcare outcomes

video | September 22, 2022

Patient journey mapping allows you to understand the pitfalls that can crop up in the healthcare journey at your healthcare organization that you weren't even aware of....

Watch Now

UniPrint Infinity for Healthcare

video | September 21, 2022

Despite all the advances in digitalization and imaging technology, printing continues to be a critical function for the healthcare industry....

Watch Now

Root Canal File Product introduction

video | September 21, 2022

Initiated in 2009, Hunan Beyond Medical Technology Co., Ltd. based in Yuelu District, Changsha with the registration capital of 30.48...

Watch Now

Spotlight

Glytec

Founded in 2006, Glytec is the pioneer and leader in diabetes therapy management software, enabling healthcare organizations to standardize acute and chronic care, and achieve best practice for glucose control. The company’s comprehensive eGlycemic Management System® (eGMS®) has been proven to dramatically reduce the drivers of cost and clinical variation, including hypoglycemia, readmissions, length of stay, complications and A1C levels. Its efficacy and safety have been validated by more than 60 research studies. eGMS® centers on an FDA-cleared insulin dosing solution that supports personalized intravenous and subcutaneous therapy for adult and pediatric populations.

Events